Medicxi's fifth specialist life-sciences vehicle, one of three European VC funds reaching at least €500 million in 2025. Its final close was reported at €500m on 14 Nov 2025. The mandate covers Europe and selected global markets. The stated stage focus is Venture, with emphasis on Health & Life Sciences.
At a glance
Related tracked funds
Source and review
This fund record was manually reviewed on by the EverythingVC editorial team under our research methodology.
The capital figure reflects commitments reported by the cited source. It is not an estimate of remaining dry powder or current fundraising availability.
- Fund announcement: PitchBook 2025 European Venture Report